Farglitazar
Clinical data | |
---|---|
Pregnancy category |
|
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 196808-45-4 |
PubChem (CID) | 170364 |
IUPHAR/BPS | 2672 |
ChemSpider | 148961 |
UNII | 3433GY7132 |
ChEMBL | CHEMBL107367 |
Chemical and physical data | |
Formula | C34H30N2O5 |
Molar mass | 546.612 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Farglitazar is a peroxisome proliferator-activated receptor agonist which is being developed by GlaxoSmithKline for the treatment of hepatic fibrosis. It is currently in phase II clinical trials.
References
This article is issued from Wikipedia - version of the 8/22/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.